收藏切换
General considerations for viral safety control in continuous manufacturing of recombinant biotechnology products
收藏切换
PDF
Wen-bo SAI, Ying-ying HU, Wei WEI
Chinese Journal of New Drugs | 2023, 32(2) : 134 - 137
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(2): 134-137
General considerations for viral safety control in continuous manufacturing of recombinant biotechnology products
Full
Wen-bo SAI, Ying-ying HU, Wei WEI
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
Published: 2023-01-30
Outline
收藏切换

Continuous manufacturing is one of the development directions of the production process of recombinant biotechnology products in the future. The promulgation of important technical documents such as ICH Q13 also provides guidance for its application practice. However, in the field of viral safety control, there are great differences in control concepts and measures between continuous manufacturing and previous batch manufacturing mode. Starting with the process characteristics of continuous manufacturing, this paper makes a preliminary discussion on three aspects, which are the control of raw materials, in-process test, and virus removal/inactivation process validation. At the same time, as the cases of continuous manufacturing of recombinant biotechnology products are still limited, more comprehensive and meticulous control strategies and measures still need further accumulated and improved based on R&D and production experience. It is suggested that the applicants of this kind of products should fully communicate with the regulatory authorities before the application, so as to ensure the safety of the subjects or patients through scientific and rigorous trial design.

recombinant biotechnology products  /  continuous manufacturing  /  raw materials  /  in-process test  /  virus removal/inactivation process validation
Wen-bo SAI, Ying-ying HU, Wei WEI. General considerations for viral safety control in continuous manufacturing of recombinant biotechnology products[J]. Chinese Journal of New Drugs, 2023 , 32 (2) : 134 -137 .
Year 2023 volume 32 Issue 2
PDF
32
12
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-01-30
Article Data
Affiliations
History
  • Accepted:2022-12-28
Affiliations
    Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT